Rajiv Patni - Feb 15, 2024 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact
Stock symbol
QNCX
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
3
Date filed
2/15/2024, 06:09 PM
Previous filing
Sep 26, 2023
Next filing
Jun 7, 2024

No securities are beneficially owned.